Europe Intradermal Injections Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Intradermal Injections Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Intradermal Injections Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Incidences of Chronic Diseases is Expected to be the Prime Driver for the Intradermal Injection Market

5.2 Market Opportunities

5.2.1 Expanding Application of Intradermal Injections in Dermatology

5.3 Future Trends

5.3.1 Strategic Developments by Manufacturers in Intradermal Injection Market

5.4 Impact of Drivers and Restraints

6. Europe Intradermal Injections Market Regional Analysis

6.1 Europe Intradermal Injections Market Overview

6.2 Europe Intradermal Injections Market Revenue 2019-2028 (US$ Million)

6.3 Europe Intradermal Injections Market Forecast Analysis

7. Europe Intradermal Injections Market Analysis – by Method

7.1 Normal Sized Needle

7.1.1 Overview
7.1.2 Normal Sized Needle: Europe Intradermal Injections Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Short Needle

7.2.1 Overview
7.2.2 Short Needle: Europe Intradermal Injections Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Without Needle

7.3.1 Overview
7.3.2 Without Needle: Europe Intradermal Injections Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Intradermal Injections Market Analysis – by Application

8.1 Tuberculin Skin Test

8.1.1 Overview
8.1.2 Tuberculin Skin Test: Europe Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Allergy Test

8.2.1 Overview
8.2.2 Allergy Test: Europe Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Local Aesthetics

8.3.1 Overview
8.3.2 Local Aesthetics: Europe Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Intradermal Injections Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Local Aesthetics: Europe Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Diagnostic Laboratories

9.2.1 Overview
9.2.2 Local Aesthetics: Europe Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Academics and Research Institutes

9.3.1 Overview
9.3.2 Local Aesthetics: Europe Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Intradermal Injections Market – Europe Analysis

10.1 Europe

10.1.1 Europe Intradermal Injections Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 Europe Intradermal Injections Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 UK: Europe Intradermal Injections Market Breakdown, by Method
10.1.1.1.2 UK: Europe Intradermal Injections Market Breakdown, by Application
10.1.1.1.3 UK: Europe Intradermal Injections Market Breakdown, by End User

10.1.1.2 Germany: Europe Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Germany: Europe Intradermal Injections Market Breakdown, by Method
10.1.1.2.2 Germany: Europe Intradermal Injections Market Breakdown, by Application
10.1.1.2.3 Germany: Europe Intradermal Injections Market Breakdown, by End User

10.1.1.3 France: Europe Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 France: Europe Intradermal Injections Market Breakdown, by Method
10.1.1.3.2 France: Europe Intradermal Injections Market Breakdown, by Application
10.1.1.3.3 France: Europe Intradermal Injections Market Breakdown, by End User

10.1.1.4 Russia: Europe Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Russia: Europe Intradermal Injections Market Breakdown, by Method
10.1.1.4.2 Russia: Europe Intradermal Injections Market Breakdown, by Application
10.1.1.4.3 Russia: Europe Intradermal Injections Market Breakdown, by End User

10.1.1.5 Italy: Europe Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Italy: Europe Intradermal Injections Market Breakdown, by Method
10.1.1.5.2 Italy: Europe Intradermal Injections Market Breakdown, by Application
10.1.1.5.3 Italy: Europe Intradermal Injections Market Breakdown, by End User

10.1.1.6 Rest of Europe: Europe Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Intradermal Injections Market Breakdown, by Method
10.1.1.6.2 Rest of Europe: Europe Intradermal Injections Market Breakdown, by Application
10.1.1.6.3 Rest of Europe: Europe Intradermal Injections Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Intradermal Injections Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 BD.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 West Pharmaceutical Services, Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Terumo Corporation.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Nanopass.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 PharmaJet.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Idevax.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Eunsung Global.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Crossject.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Cardinal Health Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Hindustan Syringes and Medical Devices Ltd.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights